Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Amelioration of Both Central and Peripheral Neuropathy in Mouse Models of Type 1 and Type 2 Diabetes by the Neurogenic Molecule NSI-189.

Jolivalt CG, Marquez A, Quach D, Navarro Diaz MC, Anaya C, Kifle B, Muttalib N, Sanchez G, Guernsey L, Hefferan M, Smith DR, Fernyhough P, Johe K, Calcutt NA.

Diabetes. 2019 Nov;68(11):2143-2154. doi: 10.2337/db19-0271. Epub 2019 Sep 6.

PMID:
31492662
2.

Murine model and mechanisms of treatment-induced painful diabetic neuropathy.

Nicodemus JM, Enriquez C, Marquez A, Anaya CJ, Jolivalt CG.

Neuroscience. 2017 Jun 23;354:136-145. doi: 10.1016/j.neuroscience.2017.04.036. Epub 2017 May 3.

3.

Spinal Disinhibition in Experimental and Clinical Painful Diabetic Neuropathy.

Marshall AG, Lee-Kubli C, Azmi S, Zhang M, Ferdousi M, Mixcoatl-Zecuatl T, Petropoulos IN, Ponirakis G, Fineman MS, Fadavi H, Frizzi K, Tavakoli M, Jeziorska M, Jolivalt CG, Boulton AJM, Efron N, Calcutt NA, Malik RA.

Diabetes. 2017 May;66(5):1380-1390. doi: 10.2337/db16-1181. Epub 2017 Feb 15.

4.

Selective antagonism of muscarinic receptors is neuroprotective in peripheral neuropathy.

Calcutt NA, Smith DR, Frizzi K, Sabbir MG, Chowdhury SK, Mixcoatl-Zecuatl T, Saleh A, Muttalib N, Van der Ploeg R, Ochoa J, Gopaul A, Tessler L, Wess J, Jolivalt CG, Fernyhough P.

J Clin Invest. 2017 Feb 1;127(2):608-622. doi: 10.1172/JCI88321. Epub 2017 Jan 17.

5.

Peripheral Neuropathy in Mouse Models of Diabetes.

Jolivalt CG, Frizzi KE, Guernsey L, Marquez A, Ochoa J, Rodriguez M, Calcutt NA.

Curr Protoc Mouse Biol. 2016 Sep 1;6(3):223-255. doi: 10.1002/cpmo.11. Review.

6.

Activation of the insulin-signaling pathway in sciatic nerve and hippocampus of type 1 diabetic rats.

King MR, Anderson NJ, Liu C, Law E, Cundiff M, Mixcoatl-Zecuatl TM, Jolivalt CG.

Neuroscience. 2015 Sep 10;303:220-8. doi: 10.1016/j.neuroscience.2015.06.060. Epub 2015 Jul 4.

7.

Efficacy of a long-acting C-peptide analogue against peripheral neuropathy in streptozotocin-diabetic mice.

Jolivalt CG, Rodriguez M, Wahren J, Calcutt NA.

Diabetes Obes Metab. 2015 Aug;17(8):781-8. doi: 10.1111/dom.12477. Epub 2015 May 20.

PMID:
25904006
8.

Role of insulin signaling impairment, adiponectin and dyslipidemia in peripheral and central neuropathy in mice.

Anderson NJ, King MR, Delbruck L, Jolivalt CG.

Dis Model Mech. 2014 Jun;7(6):625-33. doi: 10.1242/dmm.015750. Epub 2014 Apr 24.

9.

Animal models of diabetes-induced neuropathic pain.

Lee-Kubli CA, Mixcoatl-Zecuatl T, Jolivalt CG, Calcutt NA.

Curr Top Behav Neurosci. 2014;20:147-70. doi: 10.1007/7854_2014_280.

PMID:
24510303
10.

Food for thought: the role of appetitive peptides in age-related cognitive decline.

Fadel JR, Jolivalt CG, Reagan LP.

Ageing Res Rev. 2013 Jun;12(3):764-76. doi: 10.1016/j.arr.2013.01.009. Epub 2013 Feb 13. Review.

11.

Glycogen synthase kinase-3 inhibition prevents learning deficits in diabetic mice.

King MR, Anderson NJ, Guernsey LS, Jolivalt CG.

J Neurosci Res. 2013 Apr;91(4):506-14. doi: 10.1002/jnr.23192. Epub 2013 Jan 30.

12.

Hypertension-induced peripheral neuropathy and the combined effects of hypertension and diabetes on nerve structure and function in rats.

Gregory JA, Jolivalt CG, Goor J, Mizisin AP, Calcutt NA.

Acta Neuropathol. 2012 Oct;124(4):561-73. doi: 10.1007/s00401-012-1012-6. Epub 2012 Jul 13.

PMID:
22791295
13.

Similar pattern of peripheral neuropathy in mouse models of type 1 diabetes and Alzheimer's disease.

Jolivalt CG, Calcutt NA, Masliah E.

Neuroscience. 2012 Jan 27;202:405-12. doi: 10.1016/j.neuroscience.2011.11.032. Epub 2011 Dec 9.

14.

GLP-1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice.

Jolivalt CG, Fineman M, Deacon CF, Carr RD, Calcutt NA.

Diabetes Obes Metab. 2011 Nov;13(11):990-1000. doi: 10.1111/j.1463-1326.2011.01431.x.

15.

A spinal mechanism of action for duloxetine in a rat model of painful diabetic neuropathy.

Mixcoatl-Zecuatl T, Jolivalt CG.

Br J Pharmacol. 2011 Sep;164(1):159-69. doi: 10.1111/j.1476-5381.2011.01334.x.

16.

Diabetes induces changes in ILK, PINCH and components of related pathways in the spinal cord of rats.

Jiang Y, Mizisin AP, Rearden A, Jolivalt CG.

Brain Res. 2010 May 21;1332:100-9. doi: 10.1016/j.brainres.2010.03.067. Epub 2010 Mar 27.

17.

Mitochondrial respiratory chain dysfunction in dorsal root ganglia of streptozotocin-induced diabetic rats and its correction by insulin treatment.

Chowdhury SK, Zherebitskaya E, Smith DR, Akude E, Chattopadhyay S, Jolivalt CG, Calcutt NA, Fernyhough P.

Diabetes. 2010 Apr;59(4):1082-91. doi: 10.2337/db09-1299. Epub 2010 Jan 26.

18.

Type 1 diabetes exaggerates features of Alzheimer's disease in APP transgenic mice.

Jolivalt CG, Hurford R, Lee CA, Dumaop W, Rockenstein E, Masliah E.

Exp Neurol. 2010 Jun;223(2):422-31. doi: 10.1016/j.expneurol.2009.11.005. Epub 2009 Nov 18.

19.

B vitamins alleviate indices of neuropathic pain in diabetic rats.

Jolivalt CG, Mizisin LM, Nelson A, Cunha JM, Ramos KM, Bonke D, Calcutt NA.

Eur J Pharmacol. 2009 Jun 10;612(1-3):41-7. doi: 10.1016/j.ejphar.2009.04.028. Epub 2009 Apr 23.

PMID:
19393643
20.

Allodynia and hyperalgesia in diabetic rats are mediated by GABA and depletion of spinal potassium-chloride co-transporters.

Jolivalt CG, Lee CA, Ramos KM, Calcutt NA.

Pain. 2008 Nov 15;140(1):48-57. doi: 10.1016/j.pain.2008.07.005. Epub 2008 Aug 27.

21.

Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: parallels with Alzheimer's disease and correction by insulin.

Jolivalt CG, Lee CA, Beiswenger KK, Smith JL, Orlov M, Torrance MA, Masliah E.

J Neurosci Res. 2008 Nov 15;86(15):3265-74. doi: 10.1002/jnr.21787.

22.

Impaired prosaposin secretion during nerve regeneration in diabetic rats and protection of nerve regeneration by a prosaposin-derived peptide.

Jolivalt CG, Vu Y, Mizisin LM, Mizisin AP, Calcutt NA.

J Neuropathol Exp Neurol. 2008 Jul;67(7):702-10. doi: 10.1097/NEN.0b013e31817e23f4.

23.

Elevated lipid peroxidation and DNA oxidation in nerve from diabetic rats: effects of aldose reductase inhibition, insulin, and neurotrophic factors.

Cunha JM, Jolivalt CG, Ramos KM, Gregory JA, Calcutt NA, Mizisin AP.

Metabolism. 2008 Jul;57(7):873-81. doi: 10.1016/j.metabol.2008.01.021.

24.

Growth factors as therapeutics for diabetic neuropathy.

Calcutt NA, Jolivalt CG, Fernyhough P.

Curr Drug Targets. 2008 Jan;9(1):47-59. Review.

PMID:
18220712
25.

Central action of prosaptide TX14(A) against gp120-induced allodynia in rats.

Jolivalt CG, Dacunha JM, Esch FS, Calcutt NA.

Eur J Pain. 2008 Jan;12(1):76-81. Epub 2007 Apr 26.

PMID:
17466547
26.

Dynorphin A, kappa opioid receptors and the antinociceptive efficacy of asimadoline in streptozotocin-induced diabetic rats.

Jolivalt CG, Jiang Y, Freshwater JD, Bartoszyk GD, Calcutt NA.

Diabetologia. 2006 Nov;49(11):2775-85. Epub 2006 Aug 19.

PMID:
16924480
27.

Therapeutic efficacy of prosaposin-derived peptide on different models of allodynia.

Jolivalt CG, Ramos KM, Herbetsson K, Esch FS, Calcutt NA.

Pain. 2006 Mar;121(1-2):14-21. Epub 2006 Feb 9.

PMID:
16480831
28.

A novel nitric oxide scavenger in combination with cyclosporine A ameliorates experimental autoimmune encephalomyelitis progression in mice.

Jolivalt CG, Howard RB, Chen LS, Mizisin AP, Lai CS.

J Neuroimmunol. 2003 May;138(1-2):56-64.

PMID:
12742654

Supplemental Content

Loading ...
Support Center